MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Rapid blinking as an early clinical marker of Parkinson’s disease

M. Francis, T. Haque, D. Gallagher, C. Budu, A. Lee, A. Schrag, A. Noyce, C. Simonet (London, United Kingdom)

Meeting: MDS Virtual Congress 2021

Abstract Number: 1081

Keywords: Blink rate, Parkinson’s

Category: Phenomenology and Clinical Assessment of Movement Disorders

Objective: First, to determine the utility of ‘rapid blinking’ compared to spontaneous blinking in the identification of Parkinson’s disease (PD). Second, to identify whether a reduction in rapid blinking might be an early motor marker of PD in people with subthreshold parkinsonism (SP) recruited from the PREDICT-PD study.

Background: Hypomimia is an indirect marker of bradykinesia, which in turn is a critical diagnostic feature for PD. Most of the studies have focused on spontaneous blinking as a quantifiable aspect of hypomimia. However, impaired rapid blinking has also been reported as an early feature of PD (1).

Method: Spontaneous blinking was recorded during conversation with study participants (cases with PD, SP and healthy controls) for one minute. Rapid blinking was assessed and recorded by instructing participants to blink as fast as they could for 10 seconds. The task was repeated over three trials and blinking was captured on video for analysis. SP in PREDICT-PD participants was defined according to the MDS Task Force criteria for prodromal PD (2).

Results: Thirty-seven participants (PD=17, controls=12, SP= 8) took part in the study. Compared with controls, slower blink rates were recorded in patients with PD during rapid blinking (mean ± SD, PD: 3.3 ± 1.4 blinks/s vs controls: 4.5 ± 0.9 blinks/s, p=0.01), but not with spontaneous blinking (mean ± SD, PD: 0.43 ± 0.28 blinks/s vs controls: 0.65 ± 0.32 blinks/s p=0.09). Rapid blinking had acceptable discriminatory ability to differentiate PD patients from controls (AUC=0.77). The sensitivity for PD using a cut off of <4.2 blinks/s was 77% for a 75% specificity. Individuals with SP also exhibited slower rapid blinking rates compared to controls (mean ± SD, SP: 3.4 ± 0.9 blinks/s vs controls 4.5 ± 0.9 blinks/s, p=0.02).

Conclusion: Conclusion: Rapid blinking is a simple tool for distinguishing PD patients from controls and might act as an objective marker of hypomimia. Further research is needed on a larger scale to study the role of rapid blinking as an early motor marker of PD.

References: 1. Alarcón F, Maldonado JC, Cañizares M, Molina J, Noyce AJ, Lees AJ. Motor Dysfunction as a Prodrome of Parkinson’s Disease. J Parkinsons Dis. 2020;10(3):1067-73. 2. Berg D, Postuma RB, Adler CH, Bloem BR, Chan P, Dubois B, et al. MDS research criteria for prodromal Parkinson’s disease. Mov Disord. 2015;30(12):1600-11.

To cite this abstract in AMA style:

M. Francis, T. Haque, D. Gallagher, C. Budu, A. Lee, A. Schrag, A. Noyce, C. Simonet. Rapid blinking as an early clinical marker of Parkinson’s disease [abstract]. Mov Disord. 2021; 36 (suppl 1). https://www.mdsabstracts.org/abstract/rapid-blinking-as-an-early-clinical-marker-of-parkinsons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2021

MDS Abstracts - https://www.mdsabstracts.org/abstract/rapid-blinking-as-an-early-clinical-marker-of-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley